Agency Forms Undergoing Paperwork Reduction Act Review, 29861-29863 [2017-13735]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 125 / Friday, June 30, 2017 / Notices
disabilities are available upon request.
Requests for such accommodations
should be submitted via email to
fcc504@fcc.gov or by calling the
Consumer & Governmental Affairs
Bureau at (202) 418–0530 (voice), (202)
418–0432 (TTY). Such requests should
include a detailed description of the
accommodation needed. In addition,
please include a way for the FCC to
contact the requester if more
information is needed to fill the request.
Please allow at least five days’ advance
notice; last minute requests will be
accepted but may not be possible to
accommodate.
Proposed Agenda: At this meeting,
the BDAC Working Groups will report
on their progress in developing
recommendations for the BDAC’s
consideration. The BDAC also will
continue its discussions on how to
accelerate the deployment of broadband
by reducing and/or removing regulatory
barriers to infrastructure investment.
This agenda may be modified at the
discretion of the BDAC Chair and the
DFO.
Federal Communications Commission.
Daniel Kahn,
Chief, Competition Policy Division, Wireline
Competition Bureau.
[FR Doc. 2017–13687 Filed 6–29–17; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL RESERVE SYSTEM
mstockstill on DSK30JT082PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
VerDate Sep<11>2014
17:32 Jun 29, 2017
Jkt 241001
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than July 28, 2017.
A. Federal Reserve Bank of Atlanta
(Chapelle Davis, Assistant Vice
President) 1000 Peachtree Street NE.,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. WB&T Bankshares, Inc., Waycross,
Georgia; to acquire 100 percent of the
outstanding shares of Pelham Banking
Company, Pelham, Georgia.
Board of Governors of the Federal Reserve
System, June 27, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–13788 Filed 6–29–17; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Savings and Loan Holding
Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Home Owners’ Loan Act
(12 U.S.C. 1461 et seq.) (HOLA),
Regulation LL (12 CFR part 238), and
Regulation MM (12 CFR part 239), and
all other applicable statutes and
regulations to become a savings and
loan holding company and/or to acquire
the assets or the ownership of, control
of, or the power to vote shares of a
savings association and nonbanking
companies owned by the savings and
loan holding company, including the
companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the HOLA (12 U.S.C. 1467a(e)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 10(c)(4)(B) of the
HOLA (12 U.S.C. 1467a(c)(4)(B)). Unless
otherwise noted, nonbanking activities
will be conducted throughout the
United States.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
29861
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than July 28, 2017.
A. Federal Reserve Bank of Atlanta
(Chapelle Davis, Assistant Vice
President) 1000 Peachtree Street NE.,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. Charter Financial Corporation,
West Point, Georgia; to become a bank
holding company by merging with
Resurgens Bancorp, and thereby
acquiring Resurgens Bank, both of
Tucker, Georgia.
In connection with this proposal,
Charter Financial will retain ownership
of its savings association subsidiary,
CharterBank, West Point, Georgia, and
thereby engage in operating a savings
association, pursuant to section
225.28(b)(4)(ii). Finally, Charter
Financial will revert to savings and loan
holding company status after the merger
of Resurgens Bank with and into
CharterBank.
Board of Governors of the Federal Reserve
System, June 27, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–13787 Filed 6–29–17; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–17CA]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
E:\FR\FM\30JNN1.SGM
30JNN1
29862
Federal Register / Vol. 82, No. 125 / Friday, June 30, 2017 / Notices
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Positive Health Check Evaluation
Trial—New—National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
HIV transmission continues to be an
urgent public health challenge in the
United States. According to the Centers
for Disease Control and Prevention
(CDC), approximately 1.2 million people
are living with HIV, with close to 50,000
new cases each year. Antiretroviral
therapy (ART) suppresses the plasma
HIV viral load (VL) and people living
with HIV (PLWH) who are treated with
ART—compared with those who are
not—have enhanced clinical outcomes
and a substantially reduced risk of
transmitting HIV sexually, through drug
sharing, or from mother to child.
However, it is estimated that only 30%
of people who are infected with HIV in
the United States have an undetectable
HIV VL. To enhance HIV prevention
efforts, implementable, effective,
scalable interventions are needed that
focus on enhancing prevention and care
to improve the health of and reduce HIV
transmission risk among PLWH. The
Positive Health Check (PHC)
intervention is based on earlier
computer-based interventions that were
proven efficacious for HIV prevention.
The PHC intervention approach is
innovative in multiple ways. First, it
uses an interactive video doctor to
deliver tailored messages that meet
specific patient needs related to ART
initiation, adherence, sexual risk
reduction, engagement in care, motherto-child transmission, and drug use.
Second, this intervention is designed
specifically to support improved health
outcomes by providing useful behaviorchange tips for patients to practice
between clinic visits. These tips are
generated by the tool and selected by
the patient and populated on a handout
that is delivered to the patient upon
completing the PHC intervention. The
handout has no patient-identifying
information. Third, PHC supports
patient-provider communication by also
generating a set of questions that
patients may select to ask their provider.
These PHC behavior-change tips and
questions are populated on a Patient
Handout to guide patients’
conversations with their providers and
if desired, patients may choose to share
their handout with their provider. As
such, PHC supports the interactions
between patients and their providers
during their clinical encounter and is
intended to improve communication.
Finally, the PHC intervention has been
designed from the onset for wide-scale
dissemination. This web-based
intervention can be easily updated and
is accessible on multiple mobile devices
and platforms. This approach makes
PHC an important intervention strategy
to improve public health in
communities that have a high incidence
of HIV infection.
The PHC Evaluation Trial has four
primary aims: (1.) Implement a
randomized trial to test the effectiveness
of the PHC intervention for improving
clinical health outcomes, specifically
viral load and retention in care; (2.)
Conduct a feasibility assessment to
determine strategies to facilitate
implementation and integration of PHC
into the workflow of HIV primary care
clinics; (3.) Collect and document data
on the cost of PHC intervention
implementation; and (4.) Document the
standard of care at each participating
clinic. The awardee of this cooperative
agreement—Research Triangle
International (RTI)—has subcontracted
with four clinical sites to implement the
trial (Atlanta VA Medical Center
(Atlanta, GA), Hillsborough County
Health Department (Tampa, FL), Rutgers
Infectious Disease Clinic (Newark, NJ)
and Crescent Care (New Orleans, LA).
The four clinical sites) are well suited
for this work, given the high rates of
patients with elevated viral loads.
During the 36-month study period,
1,010 patients will be enrolled into the
trial (505 intervention arm and 505
control arm) across the four clinics to
evaluate the effectiveness of the PHC
intervention. Upon enrollment,
participants will be asked their date of
diagnosis. To assess the effectiveness of
the PHC intervention (Aim 1), patients
randomized to the intervention arm will
provide their responses to the patient
tailoring questions embedded within the
intervention and all enrolled patients
will consent to have their de-identified
clinical values be made available via
passive data collection via the electronic
medical record (EMR). In addition to the
main trial, three to five key staff at each
clinic site will be selected to participate
in the PHC feasibility assessment (Aim
2) which includes an online survey and
qualitative interviews. Clinic staff will
provide data on the cost of
implementing the PHC intervention
(Aim 3). Finally, the medical director of
each clinic will collect data on their
clinic’s standard of care (Aim 4).
OMB approval is requested for three
years. Participation in this study is
voluntary. The total estimated
annualized burden hours are 419.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
mstockstill on DSK30JT082PROD with NOTICES
Type of respondent
Form name
Patients Enrolled in the PHC Evaluation Trial ..............
Date of diagnosis question ..............
PHC tailoring questions ...................
Electronic Medical Record (EMR) ...
Online clinic staff survey ..................
Clinic staff qualitative interview .......
Non-research labor cost questionnaire.
Staff in PHC Evaluation Clinics .....................................
VerDate Sep<11>2014
17:32 Jun 29, 2017
Jkt 241001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
E:\FR\FM\30JNN1.SGM
337
168
4
20
20
4
30JNN1
Number of
responses per
respondent
1
3
4
4
4
1
Average
burden per
response
(in hours)
1/60
5/60
16
15/60
40/60
1.5
29863
Federal Register / Vol. 82, No. 125 / Friday, June 30, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
PHC labor cost questionnaire ..........
Standard of Care Questionnaire ......
PHC non-labor cost questionnaire ..
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–13735 Filed 6–29–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–2431–N2]
Medicaid Program: Zika Health Care
Services Program—Round 2
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
April 7, 2017 posting of a funding
opportunity for Round Two of the Zika
Health Care Services Program which
provides up to $6.45 million to support
prevention activities and treatment
services for health conditions related to
the Zika virus for entities that meet the
eligibility requirements of the Zika
Health Care Services Program, but that
did not receive an award under the
Round One Funding Opportunity. The
Round Two Funding Opportunity
provides two application due dates,
May 8, 2017 and July 10, 2017. Entities
eligible to apply for this funding
opportunity are states, territories, tribes
or tribal organizations, with active or
local transmission of the Zika virus, as
confirmed by the Centers for Disease
Control and Prevention (CDC).
DATES: The project period of
performance for the Cooperative
Agreement will be 36 months from the
date of award.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Garbarczyk, 410–786–0426.
SUPPLEMENTARY INFORMATION:
mstockstill on DSK30JT082PROD with NOTICES
SUMMARY:
I. Background
The Zika Response and Preparedness
Act (Pub. L. 114–223) provides
$387,000,000 in funding to prevent,
prepare for, and respond to the Zika
VerDate Sep<11>2014
17:32 Jun 29, 2017
Jkt 241001
virus. Of the funds appropriated by
Public Law (Pub. L.) 114–223, Congress
designated $75 million to support states,
territories, tribes, or tribal organizations
with active or local transmission cases
of the Zika virus, as confirmed by the
Centers for Disease Control and
Prevention (CDC), to reimburse the costs
of health care for health conditions
related to the Zika virus not covered by
private insurance. No less than $60
million of this funding is for territories
with the highest rates of Zika
transmission.
The Zika Health Care Services
Program funding opportunities solicit
single source emergency applications
for a cooperative agreement aimed at
supporting prevention activities and
treatment services for women (including
pregnant women), children, and men
adversely or potentially impacted by the
Zika virus.
On January 18, 2017, CMS issued
$66.1 million in awards to eligible
entities that applied for Round One of
the Zika Health Care Services Program
(American Samoa, Puerto Rico, U.S.
Virgin Islands, and Florida). The Round
One Funding Opportunity sought to
issue funds to areas of greatest need,
while maintaining additional funds to
prevent, detect, and respond to future
Zika outbreaks.
II. Provisions of the Notice
In accordance with the Zika Response
and Preparedness Act (Pub. L. 114–223),
entities eligible to apply for this funding
opportunity include states, territories,
tribes or tribal organizations with active
or local transmission of the Zika virus,
as confirmed by the Centers for Disease
Control and Prevention (CDC).
Recipients who previously received a
Notice of Award under Round One of
the Zika Health Care Services Program,
Funding Opportunity Number CMS–
1Q1–17–001, are not eligible to apply.
As of the first application due date, May
8, 2017, the CDC reports that Texas is
the only new area with laboratoryconfirmed active or local transmission
of the Zika virus; and therefore, this is
the only state currently eligible to
receive funding as authorized under the
legislation.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Number of
respondents
Form name
4
4
4
1
1
12
Average
burden per
response
(in hours)
1.5
1.5
30/60
This funding opportunity has been
structured to ensure a comprehensive
response to Zika as quickly as possible.
Accordingly, the single-source
emergency funding opportunity is solely
available to the state health department
in Texas, based on its ability to quickly
and efficiently expand its existing Zika
response efforts and to further
determine the most effective use and
dissemination of funds in its respective
jurisdictions. The health department in
Texas is uniquely positioned to meet the
goals of the emergency cooperative
agreement based on its capacity,
partnerships, resources, prior
experience, and ability to begin
implementing the project immediately.
Immediate implementation is critical to
successfully addressing this rapidly
spreading public health threat. The
budget and project period under the
specific funding opportunity will be 36
months. The total amount of federal
funds available in Round Two, for both
the May 8, 2017 and July 10, 2017 due
dates, is up to $6.45 million. The Texas
Department of State Health Services
submitted their application, and was the
only entity eligible for an award as of
the May 8, 2017 application due date.
The proposed award amount is
$1,800,000.
The second application due date for
the Round Two Funding Opportunity is
July 10, 2017. Eligibility for the second
Round Two application due date is
based on the state, territory, tribe, or
tribal organization meeting all of the
following criteria:
• Has active or local transmission
cases of the Zika virus, as confirmed by
the CDC.
• Did not receive an award in Round
One.
• Has not received a response to an
application submitted by the first
application due date (May 8, 2017).
III. Collection of Information
Requirements
This notice establishes funding
opportunities for health departments in
areas with laboratory-confirmed active
or local Zika virus transmission. The
funding opportunity application process
constitutes an information collection
request. Specifically, this notice
E:\FR\FM\30JNN1.SGM
30JNN1
]]>Agencies
[Federal Register Volume 82, Number 125 (Friday, June 30, 2017)]
[Notices]
[Pages 29861-29863]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13735]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-17CA]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
[[Page 29862]]
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (c) Enhance the
quality, utility, and clarity of the information to be collected; (d)
Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses; and (e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Positive Health Check Evaluation Trial--New--National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
HIV transmission continues to be an urgent public health challenge
in the United States. According to the Centers for Disease Control and
Prevention (CDC), approximately 1.2 million people are living with HIV,
with close to 50,000 new cases each year. Antiretroviral therapy (ART)
suppresses the plasma HIV viral load (VL) and people living with HIV
(PLWH) who are treated with ART--compared with those who are not--have
enhanced clinical outcomes and a substantially reduced risk of
transmitting HIV sexually, through drug sharing, or from mother to
child. However, it is estimated that only 30% of people who are
infected with HIV in the United States have an undetectable HIV VL. To
enhance HIV prevention efforts, implementable, effective, scalable
interventions are needed that focus on enhancing prevention and care to
improve the health of and reduce HIV transmission risk among PLWH. The
Positive Health Check (PHC) intervention is based on earlier computer-
based interventions that were proven efficacious for HIV prevention.
The PHC intervention approach is innovative in multiple ways.
First, it uses an interactive video doctor to deliver tailored messages
that meet specific patient needs related to ART initiation, adherence,
sexual risk reduction, engagement in care, mother-to-child
transmission, and drug use. Second, this intervention is designed
specifically to support improved health outcomes by providing useful
behavior-change tips for patients to practice between clinic visits.
These tips are generated by the tool and selected by the patient and
populated on a handout that is delivered to the patient upon completing
the PHC intervention. The handout has no patient-identifying
information. Third, PHC supports patient-provider communication by also
generating a set of questions that patients may select to ask their
provider. These PHC behavior-change tips and questions are populated on
a Patient Handout to guide patients' conversations with their providers
and if desired, patients may choose to share their handout with their
provider. As such, PHC supports the interactions between patients and
their providers during their clinical encounter and is intended to
improve communication. Finally, the PHC intervention has been designed
from the onset for wide-scale dissemination. This web-based
intervention can be easily updated and is accessible on multiple mobile
devices and platforms. This approach makes PHC an important
intervention strategy to improve public health in communities that have
a high incidence of HIV infection.
The PHC Evaluation Trial has four primary aims: (1.) Implement a
randomized trial to test the effectiveness of the PHC intervention for
improving clinical health outcomes, specifically viral load and
retention in care; (2.) Conduct a feasibility assessment to determine
strategies to facilitate implementation and integration of PHC into the
workflow of HIV primary care clinics; (3.) Collect and document data on
the cost of PHC intervention implementation; and (4.) Document the
standard of care at each participating clinic. The awardee of this
cooperative agreement--Research Triangle International (RTI)--has
subcontracted with four clinical sites to implement the trial (Atlanta
VA Medical Center (Atlanta, GA), Hillsborough County Health Department
(Tampa, FL), Rutgers Infectious Disease Clinic (Newark, NJ) and
Crescent Care (New Orleans, LA). The four clinical sites) are well
suited for this work, given the high rates of patients with elevated
viral loads.
During the 36-month study period, 1,010 patients will be enrolled
into the trial (505 intervention arm and 505 control arm) across the
four clinics to evaluate the effectiveness of the PHC intervention.
Upon enrollment, participants will be asked their date of diagnosis. To
assess the effectiveness of the PHC intervention (Aim 1), patients
randomized to the intervention arm will provide their responses to the
patient tailoring questions embedded within the intervention and all
enrolled patients will consent to have their de-identified clinical
values be made available via passive data collection via the electronic
medical record (EMR). In addition to the main trial, three to five key
staff at each clinic site will be selected to participate in the PHC
feasibility assessment (Aim 2) which includes an online survey and
qualitative interviews. Clinic staff will provide data on the cost of
implementing the PHC intervention (Aim 3). Finally, the medical
director of each clinic will collect data on their clinic's standard of
care (Aim 4).
OMB approval is requested for three years. Participation in this
study is voluntary. The total estimated annualized burden hours are
419.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Patients Enrolled in the PHC Date of diagnosis 337 1 1/60
Evaluation Trial. question.
PHC tailoring questions. 168 3 5/60
Staff in PHC Evaluation Clinics....... Electronic Medical 4 4 16
Record (EMR).
Online clinic staff 20 4 15/60
survey.
Clinic staff qualitative 20 4 40/60
interview.
Non-research labor cost 4 1 1.5
questionnaire.
[[Page 29863]]
PHC labor cost 4 1 1.5
questionnaire.
Standard of Care 4 1 1.5
Questionnaire.
PHC non-labor cost 4 12 30/60
questionnaire.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-13735 Filed 6-29-17; 8:45 am]
BILLING CODE 4163-18-P
